CSL subsidiary Marks World Hemophilia Day with Factor IX Donation to World Federation of Hemophilia

CSL subsidiary Marks World Hemophilia Day with Factor IX Donation to World Federation of Hemophilia

King of Prussia, PA, and Montreal, Canada — 16/04/2010

Hemophilia B patients in the developing world will benefit from a recent donation of 1 million international units (IU) of factor IX medication made by CSL Behring to the World Federation of Hemophilia (WFH). The donation will support WFH’s progress in improving the diagnosis and treatment of hemophilia in developing countries through its Global Alliance for Progress (GAP) program.


Read the entire CSL Behring Press Release
© 2016 CSL Limited